Primary Record
Ilomastat
- In stock
- 3,467 g
- Purity
- 98.2 %
- CAS
- 142880-36-2
Compound Identifiers & Properties
- CAS
- 142880-36-2
- PubChem CID
- 132519
- SMILES
- CC(C)C[C@H](CC(=O)NO)C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)NC
- Canonical SMILES
- CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](CC(=O)NO)CC(C)C
Names & Synonyms
- Ilomastat
- Galardin
- Illomastat
- 142880-36-2
- GM6001
- GM 6001
- Ilomastat [USAN]
- ilomastatum
- Llomastat
- Galardin MPI
- 4pkw
- CARBONDISULFIDE
- Ilomastat (USAN/INN)
- Ilomastat [USAN:INN]
- CS 610
- ILOMASTAT [INN]
- DTXSID0046353
- Ilomastat; GM-6001
- RefChem:790596
- GM-6001
- CHEMBL19611
- D05WSY
- D0K6UI
- D0T9HG
- Ilomastat (GM6001, Galardin)
- NITYDPDXAAFEIT-DYVFJYSZSA-N
- C20H28N4O4
- GM6001;Galardin;Ilomastat
- CBiol_001883
- MFCD00917040
- SCHEMBL35303
- BSPBio_001079
- DTXCID8026353
- KBioGR_000419
- KBioSS_000419
- UNII-I0403ML141
- CHEBI:137236
- CS-610
- AC1L314S
- GTPL7409
- orb1305084
- I0403ML141
- SCHEMBL29412562
- BCBcMAP01_000057
- CTK8F1315
- KBio2_000419
- KBio2_002987
- KBio2_005555
- KBio3_000797
- KBio3_000798
- EX-A765
- GM6001 (galardin, ilomastat)?
- BDBM234334
- Bio1_000169
- Bio1_000658
- Bio1_001147
- Bio2_000370
- Bio2_000850
- HMS1362E21
- HMS1792E21
- HMS1990E21
- HMS3403E21
- SFA88036
- ZINC3780014
- (R)-N1-((S)-3-(1H-indol-3-yl)-1-(methylamino)-1-oxopropan-2-yl)-N4-hydroxy-2-isobutylsuccinamide
- Tox21_112055
- 2433AH
- BDBM50062351
- CID132519
- GM6003
- MFCD03453614
- NCGC00163450-02
- NSC727632
- s7157
- AKOS016355429
- C20-H28-N4-O4
- ACN-051795
- CCG-207857
- CID:132519
- CS-1701
- DB02255
- NSC-727632
- IDI1_002125
- KS-0000000I
- SMP2_000212
- NCGC00163450-01
- NCGC00163450-03
- NCGC00163450-04
- AS-56152
- BC252393
- CJ-10750
- DA-73817
- HY-15768
- SID:53790355
- SID:137275749
- AB0066842
- J601.478J
- LS-186959
- LS-187605
- RT-013106
- A4050
- CAS-142880-36-2
- NS00069181
- SW218170-2
- A11456
- A13320
- D03793
- (R)-N(sup 1)-Hydroxy-N-((S)-2-indol-3-yl-1-(methylcarbamoyl)ethyl)-2-isobutylsuccinamide
- A885086
- C078131
- C119203
- (S-(R*,S*))-N(sup 4)-Hydroxy-N(sup 1)-(1H-indol-3-ylmethyl)-2-(methylamino)-2-oxoethyl)-2-(2-methylopropyl)butanediamide
- 3-(N-HYDROXYCARBOXAMIDO)-2-ISOBUTYLPROPANOYL-TRP-METHYLAMIDE
- BRD-K51662849-001-02-1
- BRD-K51662849-001-05-4
- BRD-K51662849-001-08-8
- GM 6001 - CAS 142880-36-2
- (2R)-N'-hydroxy-N-[(2S)-3-(1H-indol-3-yl)-1-(methylamino)-1-oxopropan-2-yl]-2-(2-methylpropyl)butanediamide
- B0084-302725
- N-[(2R)-2-(Hydroxamidocarbonylmethyl)-4-methylpentanoyl]-L-tryptophan Methylamide
- (R)-N4-Hydroxy-N1-[(S)-2-(1H-indol-3-yl)-1-methylcarbamoyl-ethyl]-2-isobutyl-succinamide
- N'-hydroxy-N-((S)-2-indol-3-yl-1-(methylcarbamoyl)ethyl)-2-isobutylsuccinamide
- (2R)-2-[2-(hydroxyamino)-2-oxo-ethyl]-N-[(1S)-1-(1H-indol-3-ylmethyl)-2-(methylamino)-2-oxo-ethyl]-4-methyl-pentanamide
- Butanediamide, N4-hydroxy-N1-((1S)-1-(1H-indol-3-ylmethyl)-2-(methylamino)-2-oxoethyl)-2-(2-methylpropyl)-, (2R)-
- Butanediamide, N4-hydroxy-N1-(1-(1H-indol-3-ylmethyl)-2-(methylamino)-2-oxoethyl)-2-(2-methylpropyl)-, (S-(R*,S*))-
- (R)-N*4*-Hydroxy-N*1*-[2-(1H-indol-3-yl)-1-methylcarbamoyl-ethyl]-2-isobutyl-succinamide
- (R)-N4-Hydroxy-N1-((S)-2-(1H-indol-3-yl)-1-methylcarbamoyl-ethyl)-2-isobutyl-succinamide
- N-(2(R)-2-(hydroxamidocarbonylmethyl)-4-methylpentanoyl)-L-tryptophan methylamide
- N-Methyl-Nalpha-[(2R)-2-[(hydroxycarbamoyl)methyl]-4-methylpentanoyl]-L-tryptophanamide
- Nalpha-[(2R)-2-[[(Hydroxyamino)carbonyl]methyl]-4-methylpentanoyl]-L-Trp-NHMe
- (2R)-N -Hydroxy-N-[(1S)-1-(1H-indole-3-ylmethyl)-2-(methylamino)-2-oxoethyl]-2-(2-methylpropyl)succinamide
- (2R)-N'-hydroxy-N-((1S)-2-(1H-indol-3-yl)-1-(methylcarbamoyl)ethyl)-2-(2-methylpropyl)butanediamide
- (2R)-N'-hydroxy-N-((2S)-3-(1H-indol-3-yl)-1-methylamino-1-oxopropan-2-yl)-2-(2-methylpropyl)butanediamide
- (2R)-N'-hydroxy-N-[(1S)-2-(1H-indol-3-yl)-1-(methylcarbamoyl)ethyl]-2-(2-methylpropyl)butanediamide
- (2R)-N'-hydroxy-N-[(2S)-3-(1H-indol-3-yl)-1-methylamino-1-oxopropan-2-yl]-2-(2-methylpropyl)butanediamide
- (2R)-N(4)-hydroxy-N(1)-[(2S)-3-(1H-indol-3-yl)-1-(methylamino)-1-oxopropan-2-yl]-2-(2-methylpropyl)butanediamide
- (2R)-N-[(1S)-1-(1H-Indole-3-ylmethyl)-2-(methylamino)-2-oxoethyl]-2-(2-methylpropyl)-N -hydroxybutanediamide
- (2R)-N-[(S)-1-[(1H-Indole-3-yl)methyl]-2-(methylamino)-2-oxoethyl]-N -hydroxy-2-isobutylbutanediamide
- (2R)-N~4~-hydroxy-N~1~-[(1S)-1-(1H-indol-3-ylmethyl)-2-(methylamino)-2-oxoethyl]-2-(2-methylpropyl)butanediamide
- (2R)-N~4~-Hydroxy-N~1~-[(2S)-3-(1H-indol-3-yl)-1-(methylamino)-1-oxopropan-2-yl]-2-(2-methylpropyl)butanediamide
- (2R)-N4-Hydroxy-N1-[(1S)-1-(1H-indol-3-ylmethyl)-2-(methylamino)-2-oxoethyl]-2-(2-methylpropyl)butanediamide
- (R)-N*4*-Hydroxy-N*1*-[(S)-2-(1H-indol-3-yl)-1-methylcarbamoyl-ethyl]-2-isobutyl-succinamide
- Butanediamide, N4-hydroxy-N1-((1S)-1-(1H-indol-3-ylmethyl)-2-(methylamino)-2-oxoethyl)-2-(2-methylpropyl)-,(2R)-
- GM6